The Fluoroscopy and Mobile C-Arms Market size is projected to reach USD 4.32 Billion by 2032 at 4.7% CAGR during the forecast period 2023-2032. Fluoroscopy is a medical imagining which is used to generate continuous real-time images, more like an X-ray movie or short video of the patient’s bodies. Fluoroscopy is a medical imaging tactic that helps to generate multiple X-rays on the monitor. On the other hand, the C arm has radiographic capabilities which are used to attach the X-ray detector and X-ray source with each other. This device is widely used for the surgical imagining of fluoroscopic surgeries, imagining of procedures of emergency care, and orthopedic. Fluoroscopy and C-arm are extensively used for the treatments of the various body parts that include peripheral artery disease (PAD), pulmonary embolism, spinal cord injury, deep vein thrombosis, abdominal aortic aneurysms, and other chronic condition.
Fluoroscopy and C-arm are extensively used for interventional radiological procedures. The growing universality of chronic diseases, increase in the population, and the adoption or appropriation of the devices in the medical field is the biggest reason for driving the growth of the global fluoroscopy and mobile C-arm.
However, there are few restrictions or hurdles in the growth of the market among which the high cost of the C-arm and fluoroscope device are the major causes, that is restricting the growth of the market during the forecast period. Apart from this, there is the availability of proxy devices in the market which is also harming the growth. The high risk of radiation exposure can also be considered as a hurdle in the growth of the market during or over the forecast period.
This report basically focuses on the overall fluoroscopy and c-arm market and its strengths through the explanations of the market researches. Along with that, the report also includes the high point of the market dynamics, segmentation, key players, and other important factors.
Covid 19 Analysis:The covid 19 pandemics are anticipated to have a clash on the fluoroscopy and mobile C arm market. The hospitals are more determined to invest in high-cost covid 19 types of equipment or ventilators which might affect the fluoroscopy and mobile C-arm market. Based on the latest study, there is an article published in May 2020 in the British Journal of Surgery, based on the article, around 28.4 Million surgeries around the globe were postponed or canceled due to the covid 19 and 580,000 surgeries were canceled or postponed alone in India.
Therefore, the vaccines are already in the market and the government is continuously working for the betterment of the society which will eventually help the steady growth of fluoroscopy and mobile C-arm market during the forecast period.
The growth of the global market of Fluoroscopy and mobile C-arm market is driven by a number of factors. The increasing incidences of chronic diseases and the rising geriatric population are the major cause for the growth of the market. The preferences of the doctors around the globe for fluoroscopy and neurology and orthopedic procedures are other factors.
According to the study, the annual incident rates of RA and age-standardized point generality were 246.6 and 14.9 in 2017 which increased by 7.4% and 8.2% from 1990.
The fluoroscopy and mobile C-arm devices are highly used by doctors worldwide for older patients. Proper types of equipment and tools are required to operate and this device helps to monitor the whole surgical procedures as slight errors or mistakes could cause serious damage to the older patients.
Moreover, imaged guided surgeries are chiefly preferred by the doctors to serve the geriatric population with perfection, the risk of complications can be reduced with the help of the mobile C-arms.
The acquisition of alternative or substitution techniques for fluoroscopy is likely to affect the growth of the market. Fluoroscopy and C-arm techniques help the surgeons to perform infinitesimal invasive surgery procedures. There is a high risk of ionizing radiation with the fluoroscopy devices, and due to that several physicians prefer other alternatives such as ultrasonography.
Therefore, there is a high demand for refurbished equipment which is cheaper as compared to fluoroscopy devices. The growth in the demand for the refurbished equipment has affected the fluoroscopy market. The price of refurbished equipment ranges from US$ 5,000 to US$ 140,000 on the other hand the price of C-arm devices reaches up to US$ 200,000
Fluoroscopy’s artificial intelligence offers a profitable growth opportunity for the key players in the global fluoroscopy and c-arm market size. According to a study, in October 2019, the American College Of Gastroenterology has reported that the use of the fluoroscopic system with artificial intelligence can minimize the threat of exposure to radiation.
The growth of the market is highly affected by this new development of technology. The CorPath GRX System with the robotic PCI has reduced the exposure of the radiation by 20% as compared to the PCI.
The adoption of the fluoroscopy and c-arm market size is anticipated to toss growth in the global market during the forecast period. AIIMS Bhopal, India, established a Digital Radiography Fluoroscopy unit in the hospital.
Major key players around the globe are focused on getting the approvals and launching new devices to extend the portfolio of the product. In March 2019, Philips got the clearance for a digital radiographic-fluoroscopy system which is a ProxiDiagnost N90.
Fluoroscopy and mobile c-arms market trends have basically three segments which are generally based on the application, different types of devices, and end-users. The fluoroscopy and mobile c-arm market are divided into two types on the basis of the device, one is mobile C arm and another is fluoroscopy system. The subdivision of the market on the basis of application includes pain management and trauma, gastrointestinal orthopedics, cardiovascular, neurology, urology, and others. On the basis of the end-users, the market has been segmented into diagnostic centers, hospitals and clinics, research and academic institutes, and others, The market value of hospitals and clinic has experienced USD 895.96Million in 2017.
The global fluoroscopy and C-arm market have categorized on the basis of the application and end-users. On the basis of the product types, C-arm is estimated to interpretive for 74.4% revenue share of the global market by the end of 2016. In the end-user section, the hospitals and clinic segments are expected to reach US$ 3522.6Mn by 2024 with a CAGR of 4.9% over the forecast period.
On the basis of the application, the market is divided into different segments including urology, neurology, orthopedics, gastrointestinal, pain management and trauma, cardiovascular, and others.
In 2017, the market has experienced a reach of USD 895.96 Million in the hospital and clinic segments. The market of the end-user has been segmented into research and clinic institutes, diagnostic centers, hospitals and clinics, and others.
The global market of fluoroscopy and mobile c-arm, on the basis of regions, is divided into America, Europe, Asia Pacific, and the Middle East and Africa. America is expected to be the largest sector to influence the global fluoroscopy and c-arm mobile market, especially in North America. The rise in the awareness of the new technology, the acceptance of innovative and new products, and the financial capability of the country to purchase the expensive devices are the leading cause of the growth in the market.
The European countries are showing tremendous growth in the market by increasing healthcare expenditure, increased amount of road accidents increases the demands o the orthopedic surgeries in European regions and R&D activities are the major causes for the growth of fluoroscopy and mobile c arm market value globally.
The major terminus for outsourcing pathology testing and clinical trials are the developing countries of Pacific-Asia that includes India, South Korea, and China. In 2017, in the pacific-Asia, China accounted for 19.6% of shares, according to the MRFR analysis and due to the low expendable income, the Middle East and Africa has the least amount of fluoroscopy and mobile c-arms market share.
Competitive landscape
The c-arm market is highly completive and amalgamated. Major players are considering trying to get competitive advantages by upgrading the current product lines and also by introducing product innovations. The c-arm has registered an enormous competition because of the launches of several new innovative products. Siemens Healthineers has received FDA approval for a mobile c-arm named Cios Flow which is designed for multipurpose use in the operating room.
Top key players of the fluoroscopy and mobile c-arm market:
Recent Developments:
Two new systems named the Persona C Surgical C-Arm and Persona RF PREMIUM System was introduced in Nov 2020, by FUJIFILM Medical System USA IncThe completion of BioPharma business sale to Danaher Corporation for approximately USD 20 billion, has been announced by GE in Mar 2020.
The following report comprises of –
Challenges
This report is to point out the high points of the Fluoroscopy and mobile c-arms market in terms of the revenue hike by end of the global forecast year 2023.
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â 4.32 Billion |
| Â Â CAGR | Â Â 4.7% |
| Â Â Base Year | Â Â 2022 |
| Â Â Forecast Period | Â Â 2023-2032 |
| Â Â Historical Data | Â Â 2021 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Device Type, Application, End User |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â Allengers Medical Systems (India), Canon Medical Systems Corporation (Japan), DMS Group (France), GE Healthcare (US), Hitachi Ltd (Tokyo), Hologic Inc. (US), Omega Medical Imaging, LLC (US), OrthoScan Inc. (US), Koninklijke Philips N.V. (The Netherlands), Shimadzu Corporation (Japan), Siemens (Germany), Varian Medical Systems, Inc. (US), Villa Sistemi Medicali Spa (Italy), Ziehm Imaging GmbH (US) |
| Â Â Key Market Opportunities | Â Â New product launches and R&D Amongst major key Players |
|   Key Market Drivers | · Increasing incidences of chronic diseases· The rising geriatric population |
Fluoroscopy Mobile C-Arms Market Highlights:
Frequently Asked Questions (FAQ) :
The fluoroscopy and mobile c-arms market is anticipated to reach USD 4.32 Billion in 2032.
The fluoroscopy and mobile c-arms market is anticipated to reach a strong CAGR of 4.7%, over the forecast period.
The growing prevalence of chronic diseases such as deep vein thrombosis and peripheral artery disease is the major driver for the fluoroscopy and mobile c-arms market.
The Americas is expected to dominate the fluoroscopy and mobile c-arms market due to the widespread adoption of advanced medical technology in the region.
Leading players in the fluoroscopy and mobile c-arms market include Allengers Medical Systems, GE Healthcare, DMS Group, Canon, and Hologic, among others.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
